From professional translators, enterprises, web pages and freely available translation repositories.
panitumumab
panitumumabas
Last Update: 2014-11-21
Usage Frequency: 2
Quality:
panitumumab + folfiri
panitumumabas + folfiri
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each vial contains 200 mg panitumumab.
viename buteliuke yra 200 mg panitumumabo.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
each vial contains 100 mg of panitumumab.
viename buteliuke yra 100 mg panitumumabo.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
it contains the active substance panitumumab.
jo sudtyje yra veikliosios medziagos panitumumabo.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
each ml of concentrate contains 20 mg panitumumab.
viename mililitre koncentrato yra 20 mg panitumumabo.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
vectibix 20 mg/ml sterile concentrate panitumumab
vectibix 20 mg/ml sterilus koncentratas panitumumab i.v.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substance is panitumumab 20 mg/ml.
veiklioji medziaga yra panitumumabas.viename mililitre koncentrato jo yra 20 mg.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
vectibix 20 mg/ ml sterile concentrate panitumumab iv
vectibix 20 mg/ ml sterilus koncentratas panitumumab i. v.
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
there was an increase in mortality in the panitumumab arm.
panitumumabu gydytų pacientų grupėje mirtingumas buvo didesnis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vectibix 20 mg/ ml concentrate for solution for infusion panitumumab
vectibix 20 mg/ ml koncentratas infuziniam tirpalui panitumumabas (panitumumab)
Last Update: 2012-04-11
Usage Frequency: 3
Quality:
colourless solution that may contain visible amorphous panitumumab particles.
bespalvis tirpalas, kuriame gali bti matom amorfini panitumumabo daleli.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
panitumumab may impact the ability of a woman to become pregnant.
panitumumabas gali veikti moters gebėjimą pastoti.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
panitumumab does not seem to work in tumour cells that contain mutated kras.
panitumumabas neveiksmingas naviko lstelse, kuriose yra mutavs kras.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
lactation it is unknown whether panitumumab is excreted in human breast milk.
zindymo laikotarpisnezinoma, ar panitumumabo patenka motinos pien.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
panitumumab does not seem to work in tumour cells that contain mutated ras genes.
panašu, kad panitumumabas neveikia naviko, kuriame yra mutavę ras genai, ląstelių.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
studies to evaluate the mutagenic and carcinogenic potential of panitumumab have not been performed.
tyrimų, kuriais galima įvertinti panitumumabo gebėjimą sukelti mutageninį ir kancerogeninį poveikį, neatlikta.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
this may be due to patients receiving panitumumab after progression among those randomized to bsc.
taip galjo bti dl to, kad vien tik tpg gav pacientai, kuri liga progresavo, pradjo vartoti panitumumab.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
no pre- and post-natal development animal studies have been conducted with panitumumab.
panitumumabo poveikio prenataliniam ir postnataliniam gyvūnų vystymuisi tyrimų neatlikta.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
skin reactions were the most frequently occurring adverse reactions in patients receiving panitumumab in combination with chemotherapy.
odos reakcijos buvo dažniausios nepageidaujamos reakcijos pasireiškusios pacientams, vartojantiems panitumumabą kartu su chemoterapija.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: